The CRO concept sector continued to rise. Gloria Ying rose and stopped, Cansino rose more than 10%, and Chengdu Pioneer, Hongbo Pharmaceuticals, Novizan, Kanglong Chemical, and Zhaoyan New Pharmaceuticals followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.